哮喘-慢性阻塞性肺疾病重疊的臨床研究和診斷標準進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

嵇華夏 ¹ , 周勤 ¹ ,  孫書明 ²

1. ;
2. ;

Corresponding?author：

孫書明, Email: zhh1314jhx@163.com

Keywords：

DOI：

10.7507/1671-6205.201610030

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 嵇華夏, 周勤, 孫書明. 哮喘-慢性阻塞性肺疾病重疊的臨床研究和診斷標準進展. Chinese Journal of Respiratory and Critical Care Medicine, 2017, 16(4): 407-413. doi: 10.7507/1671-6205.201610030 Copy

1.	Global strategy for asthma management and prevention[R/OL]. Global Initiative for Asthma (GINA). [2015-04-13]. Available at: http://ginasthma.org/.
2.	Global strategy for the diagnosis, management, and prevention of COPD[R/OL]. Global Initiative for Chronic Obstructive Lung Disease (GOLD). [2015-04-13]. Available at: http://goldcopd.org/.
3.	Jeffery PK. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2004, 1(3): 176-183.
4.	Global Strategy for Asthma Management and Prevention, 2017[R/OL]. Global Initiative for Asthma. [2017-04-13]. Available at: http://ginasthma.org/.
5.	Postma DS, Reddel HK, ten Hacken NH, et al. Asthma and chronic obstructive pulmonary disease: similarities and differences. Clin. Chest Med, 2014, 63(5-6): 332.
6.	Kim TB, Oh YM, Chang YS, et al. The reality of an intermediate type between asthma and COPD in practice. Respir Care, 2012, 57(8): 1248-1253.
7.	Miravitlles M, Andreu I, Romero Y, et al. Difficulties in differential diagnosis of COPD and asthma in primary care. Br J Gen Pract, 2012, 62(595): e68-75.
8.	Braman SS. The chronic obstructive pulmonary disease-asthma overlap syndrome. Allergy Asthma Proc, 2015, 36(36): 11.
9.	申景文, 王緒飛. 哮喘和慢性阻塞性肺疾病重疊的治療策略]. 世界最新醫學信息文摘, 2015, 15(16): 92-93.
10.	Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma, 2011, 48(3): 279-285.
11.	Miravitlles M, Soler-Cataluna JJ, Calle M, et al. Spanish guideline for COPD (GesEPOC). Update 2014. Arch. Bronconeumol, 2014, 50(Suppl.1): 1-16.
12.	Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. COPD, 2011, 8(6): 400-407.
13.	de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middleaged and elderly people from the general population. PLoS ONE, 2013, 8(5): e62985.
14.	張弘, 蔡柏薔. 支氣管哮喘慢性阻塞性肺疾病重疊綜合征簡介. 中華結核和呼吸雜志, 2014, 37(9): 713-715.
15.	Milanese M, Di Marco F, Corsico AG, et al. Asthma control in elderly asthmatics. An Italian observational study. Respir. Med, 2014, 108(8): 1091-1099.
16.	Golpe R, Sanjuan Lopez P, Cano Jimenez E, et al. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke. Arch. Bronconeumol, 2014, 50(8): 318-324.
17.	Miravitlles M, Huerta A, Fernandez-Villar JA, et al. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems. Health Qual. Life Outcomes, 2014, 12(1): 120.
18.	Kitaguchi Y, Komatsu Y, Fujimoto K, et al. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int. J. Chron. Obstruct. Pulmon. Dis, 2012, 7(1): 283-289.
19.	Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir. Res, 2011, 12(1): 1-8.
20.	Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes. Thorax, 2008, 63(9): 761-767.
21.	Fu JJ, Gibson PG, Simpson JL, et al. Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome. Respiration, 2014, 87(1): 63-74.
22.	Andersen H, Lampela P, Nevanlinna A, et al. High hospital burden in overlap syndrome of asthma and COPD. Clin. Respir. J, 2013, 7(4): 342-346.
23.	Menezes AM, Montes de Oca M, Perez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest, 2014, 145(2): 297-304.
24.	Chung JW, Kong KA, Lee JH, et al. Characteristics and self-rated health of overlap syndrome. Int. J. Chron. Obstruct. Pulmon. Dis, 2014, 9(1): 795-804.
25.	Toy EL, Gallagher KF, Stanley EL, et al. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD, 2010, 7(3): 214-228.
26.	Blanchette CM, Gutierrez B, Ory C, et al. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. J. Manag. Care Pharm, 2008, 14(2): 176-185.
27.	Rhee CK, Yoon HK, Yoo KH, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD, 2014, 11(2): 163-170.
28.	Shaya FT, Dongyi D, Akazawa MO, et al. Burden of concomitant asthma and COPD in a Medicaid population. Chest, 2008, 134(1): 14-19.
29.	錢小順, 李天志, 王俊鋒. 老年人慢性阻塞性肺病的臨床特點分析. 中華老年多器官疾病雜志. 2008, 7(6): 485-488.
30.	Hardin M, Cho M, McDonald ML, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur. Respir. J, 2014, 44(2): 341-350.
31.	Miravitlles M, Soriano JB, Ancochea J, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir. Med, 2013, 107(7): 1053-1060.
32.	Fattahi F, ten Hacken NH, Lofdahl CG, et al. Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study. Respir. Res, 2013, 14(1): 10.
33.	Christenson SA, Steiling K, van den Berge M, et al. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med, 2015, 191(7): 758-766.
34.	Mauad T, Dolhnikoff M. Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med, 2008, 14(14): 31-38.
35.	Guerra S, Martinez FD. Epidemiology of the origins of airflow limitation in asthma. Proc. Am. Thorac. Soc, 2009, 6(8): 707-711.
36.	Postma DS, Kerkhof M, Boezen HM, et al. Asthma and chronic obstructive pulmonary disease: common genes, common environments? Am. J. Respir. Crit. Care Med, 2011, 183(12): 1588-1594.
37.	Shirtcliffe P, Marsh S, Travers J, et al. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Intern. Med. J, 2012, 42(1): 83-88.
38.	Aanerud M, Carsin AE, Sunyer J, et al. Interaction between asthma and smoking increases the risk of adult airway obstruction. Eur. Respir. J, 2015, 45(3): 635-643.
39.	James AL, Palmer LJ, Kicic E, et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am. J. Respir. Crit. Care Med, 2005, 171(2): 109-114.
40.	Perret JL, Dharmage SC, Matheson MC, et al. The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. Am. J. Respir. Crit. Care Med, 2013, 187(1): 42-48.
41.	孫永昌. 慢性阻塞性肺疾病與支氣管哮喘并存的診治問題. 中華結核和呼吸雜志, 2012, 35(4): 297-299.
42.	Broekema M, ten Hacken NH, Volbeda F, et al. Airway epithelial changes in smokers but not in ex-smokers with asthma. Am J Respir Crit Care Med, 2009, 180(12): 1170-1178.
43.	Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet, 2010, 376: 803-813.
44.	van Schayck CP, Levy ML, Chen JC, et al. Coordinated diagnostic approach for adult obstructive lung disease in primary care. Prim Care Respir J. 2004, 13(4): 218-221.
45.	Barrecheguren M, Esquinas C, Miravitlles M. The asthmachronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr Opin Pulm Med, 2015, 21(1): 74-79.
46.	Tzortzaki EG, Proklou A, Siafakas NM. Asthma in the elderly: can we distinguish it from COPD? J Allergy (Cairo) 2011, 2011(2011): 843543.
47.	Zeki AA, Schivo M, Chan A, et al. The asthma-COPD overlap syndrome: a common clinical problem in the elderly. J Allergy (Cairo) 2011, 2011(6): 861926.
48.	侯超, 胡曉帆, 劉婷, 等. 哮喘長期管理方法的研究進展. 中華肺部疾病雜志電子版, 2013, 6(5): 55-59.
49.	Abramson MJ, Perret JL, Dharmage SC, et al. Distinguishing adult-onset asthma from COPD: a review and a new approach. Int J Chron Obstruct Pulmon Dis, 2014, 9: 945-962.
50.	Lee JH, Haselkorn T, Borish L, et al. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest, 2007, 132(6): 1882-1889.
51.	沈寧, 賀蓓. 應用噻托溴銨治療成人未控制哮喘. 中華醫學雜志, 2010, 90(42): 2955-2955.
52.	沈寧, 馬洪明, 陳秋冬, 等. 白三烯受體拮抗劑作為哮喘控制一線或附加治療藥物的評價. 中華醫學雜志, 2011, 91(28): 1960-1960.
53.	Korn D, Van den Brande P, Potvin E, et al. Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study. Curr Med Res Opin, 2009, 25(2): 489-497.
54.	Mirabelli MC, Beavers SF, Chatterjee AB. Active asthma and the prevalence of physician-diagnosed COPD. Lung, 2014, 192(5): 693-700.
55.	Tashkin DP. Is it asthma, COPD, or something in between, and does it matter? Respiratory Care, 2012, 57(8): 1354-1356.
56.	Tinkelman DG, Price DB, Nordyke RJ, et al. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma, 2006, 43(1): 75-80.
57.	Burgess JA, Walters EH, Byrnes GB, et al. Who remembers whether they had asthma as children? J Asthma, 2006, 43(10): 727-730.
58.	Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008, 31(4): 742-750.
59.	D’Silva L, Hassan N, Wang HY, et al. Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice. Can Respir J, 2011, 18(3): 144-148.
60.	Hancox RJ, Cowan DC, Aldridge RE, et al. Asthma phenotypes: consistency of classification using induced sputum. Respirology, 2012, 17(3): 461-466.
61.	Van fleteren LE, Kocks JW, Stone IS, et al. Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? Thorax, 2014, 69(1): 72-79.
62.	Nakawah MO, Hawkins C, Barbandi F. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome. J. Am. Board Fam. Med, 2013, 26(4): 470-477.
63.	Louie S, Zeki AA, Schivo M, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev, Clin. Pharmacol, 2013, 6(2): 197-219.
64.	鄧玎玎, 周愛媛, 雙慶翠, 等. 支氣管哮喘-慢性阻塞性肺疾病重疊綜合征的診斷及治療現狀. 國際呼吸雜志. 2016, 13: 1023-1027.
65.	Diaz-Guzman E, Mannino DM. Airway obstructive diseases in older adults: from detection to treatment. J Allergy Clin Immunol, 2010, 126(4): 702-709.
66.	孟珊珊, 閆冰迪, 王艷軍, 等. 支氣管哮喘-慢性阻塞性肺疾病重疊綜合征265例. 實用醫學雜志, 2015, 31(3): 437-438.
67.	Montuschi P, Malerba M, Santini G, et al. Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping. Drug Discov Today, 2014, 19(12): 1928-1935.
68.	Welte T, Miravitlles M, Hernandez P, et al. Efficacy and tolerability of budesonide/ formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2009, 180(8): 741-750.
69.	Gershon AS, Campitelli MA, Croxford R, et al. Combination long-acting beta-agonists and inhaled corticosteroids compared with long acting beta-agonists alone in older adults with chronic obstructive pulmonary disease. JAMA, 2014, 312(11): 1114-1121.
70.	Magnussen H, Bugnas B, van Noord J, et al. Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med, 2008, 102(1): 50-56.
71.	Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N. Engl. J. Med, 2010, 363(18): 1715-1726.
72.	Miravitlles M, Soler-Cataluna JJ, Calle M, et al. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J, 2013, 41(6): 1252-1256.
73.	Leigh R, Pizzichini MM, Morris MM, et al. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J, 2006, 27(5): 964-971.
74.	Chanez P, Vignola AM, O’Shaugnessy T, et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit CareMed, 1997, 155(5): 1529-1534.
75.	Tomlinson JE, McMahon AD, Chaudhuri R, et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax, 2005, 60(4): 282-287.
76.	Bellia V, Pistelli R, Catalano F, et al. Quality control of spirometry in the elderly. The SA. R. A. study. SAlute Respiration nell’Anziano=Respiratory Health in the Elderly. Am J Respir Crit Care Med, 2000, 161(4): 1094-1100.
77.	McDonald VM, Higgins I, Gibson PG. Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges. Drugs Aging, 2013, 30(1): 1-17.
78.	Contoli M, Baraldo S, Marku B, et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. J Allergy Clin Immunol, 2010, 125(4): 830-837.
79.	Lange P, Celli B, Agusti A, et al. Lungfunction trajectories leading to chronic obstructive pulmonary disease. N Engl J Med, 2015, 373(2): 111-122.
80.	Pavord ID. Complex airway disease: an approach to assessment and management. Lancet Respir Med. 2013, 1(1): 84-90.

1. Global strategy for asthma management and prevention[R/OL]. Global Initiative for Asthma (GINA). [2015-04-13]. Available at: http://ginasthma.org/.
2. Global strategy for the diagnosis, management, and prevention of COPD[R/OL]. Global Initiative for Chronic Obstructive Lung Disease (GOLD). [2015-04-13]. Available at: http://goldcopd.org/.
3. Jeffery PK. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2004, 1(3): 176-183.
4. Global Strategy for Asthma Management and Prevention, 2017[R/OL]. Global Initiative for Asthma. [2017-04-13]. Available at: http://ginasthma.org/.
5. Postma DS, Reddel HK, ten Hacken NH, et al. Asthma and chronic obstructive pulmonary disease: similarities and differences. Clin. Chest Med, 2014, 63(5-6): 332.
6. Kim TB, Oh YM, Chang YS, et al. The reality of an intermediate type between asthma and COPD in practice. Respir Care, 2012, 57(8): 1248-1253.
7. Miravitlles M, Andreu I, Romero Y, et al. Difficulties in differential diagnosis of COPD and asthma in primary care. Br J Gen Pract, 2012, 62(595): e68-75.
8. Braman SS. The chronic obstructive pulmonary disease-asthma overlap syndrome. Allergy Asthma Proc, 2015, 36(36): 11.
9. 申景文, 王緒飛. 哮喘和慢性阻塞性肺疾病重疊的治療策略]. 世界最新醫學信息文摘, 2015, 15(16): 92-93.
10. Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma, 2011, 48(3): 279-285.
11. Miravitlles M, Soler-Cataluna JJ, Calle M, et al. Spanish guideline for COPD (GesEPOC). Update 2014. Arch. Bronconeumol, 2014, 50(Suppl.1): 1-16.
12. Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. COPD, 2011, 8(6): 400-407.
13. de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middleaged and elderly people from the general population. PLoS ONE, 2013, 8(5): e62985.
14. 張弘, 蔡柏薔. 支氣管哮喘慢性阻塞性肺疾病重疊綜合征簡介. 中華結核和呼吸雜志, 2014, 37(9): 713-715.
15. Milanese M, Di Marco F, Corsico AG, et al. Asthma control in elderly asthmatics. An Italian observational study. Respir. Med, 2014, 108(8): 1091-1099.
16. Golpe R, Sanjuan Lopez P, Cano Jimenez E, et al. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke. Arch. Bronconeumol, 2014, 50(8): 318-324.
17. Miravitlles M, Huerta A, Fernandez-Villar JA, et al. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems. Health Qual. Life Outcomes, 2014, 12(1): 120.
18. Kitaguchi Y, Komatsu Y, Fujimoto K, et al. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int. J. Chron. Obstruct. Pulmon. Dis, 2012, 7(1): 283-289.
19. Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir. Res, 2011, 12(1): 1-8.
20. Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes. Thorax, 2008, 63(9): 761-767.
21. Fu JJ, Gibson PG, Simpson JL, et al. Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome. Respiration, 2014, 87(1): 63-74.
22. Andersen H, Lampela P, Nevanlinna A, et al. High hospital burden in overlap syndrome of asthma and COPD. Clin. Respir. J, 2013, 7(4): 342-346.
23. Menezes AM, Montes de Oca M, Perez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest, 2014, 145(2): 297-304.
24. Chung JW, Kong KA, Lee JH, et al. Characteristics and self-rated health of overlap syndrome. Int. J. Chron. Obstruct. Pulmon. Dis, 2014, 9(1): 795-804.
25. Toy EL, Gallagher KF, Stanley EL, et al. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD, 2010, 7(3): 214-228.
26. Blanchette CM, Gutierrez B, Ory C, et al. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. J. Manag. Care Pharm, 2008, 14(2): 176-185.
27. Rhee CK, Yoon HK, Yoo KH, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD, 2014, 11(2): 163-170.
28. Shaya FT, Dongyi D, Akazawa MO, et al. Burden of concomitant asthma and COPD in a Medicaid population. Chest, 2008, 134(1): 14-19.
29. 錢小順, 李天志, 王俊鋒. 老年人慢性阻塞性肺病的臨床特點分析. 中華老年多器官疾病雜志. 2008, 7(6): 485-488.
30. Hardin M, Cho M, McDonald ML, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur. Respir. J, 2014, 44(2): 341-350.
31. Miravitlles M, Soriano JB, Ancochea J, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir. Med, 2013, 107(7): 1053-1060.
32. Fattahi F, ten Hacken NH, Lofdahl CG, et al. Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study. Respir. Res, 2013, 14(1): 10.
33. Christenson SA, Steiling K, van den Berge M, et al. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med, 2015, 191(7): 758-766.
34. Mauad T, Dolhnikoff M. Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med, 2008, 14(14): 31-38.
35. Guerra S, Martinez FD. Epidemiology of the origins of airflow limitation in asthma. Proc. Am. Thorac. Soc, 2009, 6(8): 707-711.
36. Postma DS, Kerkhof M, Boezen HM, et al. Asthma and chronic obstructive pulmonary disease: common genes, common environments? Am. J. Respir. Crit. Care Med, 2011, 183(12): 1588-1594.
37. Shirtcliffe P, Marsh S, Travers J, et al. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Intern. Med. J, 2012, 42(1): 83-88.
38. Aanerud M, Carsin AE, Sunyer J, et al. Interaction between asthma and smoking increases the risk of adult airway obstruction. Eur. Respir. J, 2015, 45(3): 635-643.
39. James AL, Palmer LJ, Kicic E, et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am. J. Respir. Crit. Care Med, 2005, 171(2): 109-114.
40. Perret JL, Dharmage SC, Matheson MC, et al. The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. Am. J. Respir. Crit. Care Med, 2013, 187(1): 42-48.
41. 孫永昌. 慢性阻塞性肺疾病與支氣管哮喘并存的診治問題. 中華結核和呼吸雜志, 2012, 35(4): 297-299.
42. Broekema M, ten Hacken NH, Volbeda F, et al. Airway epithelial changes in smokers but not in ex-smokers with asthma. Am J Respir Crit Care Med, 2009, 180(12): 1170-1178.
43. Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet, 2010, 376: 803-813.
44. van Schayck CP, Levy ML, Chen JC, et al. Coordinated diagnostic approach for adult obstructive lung disease in primary care. Prim Care Respir J. 2004, 13(4): 218-221.
45. Barrecheguren M, Esquinas C, Miravitlles M. The asthmachronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr Opin Pulm Med, 2015, 21(1): 74-79.
46. Tzortzaki EG, Proklou A, Siafakas NM. Asthma in the elderly: can we distinguish it from COPD? J Allergy (Cairo) 2011, 2011(2011): 843543.
47. Zeki AA, Schivo M, Chan A, et al. The asthma-COPD overlap syndrome: a common clinical problem in the elderly. J Allergy (Cairo) 2011, 2011(6): 861926.
48. 侯超, 胡曉帆, 劉婷, 等. 哮喘長期管理方法的研究進展. 中華肺部疾病雜志電子版, 2013, 6(5): 55-59.
49. Abramson MJ, Perret JL, Dharmage SC, et al. Distinguishing adult-onset asthma from COPD: a review and a new approach. Int J Chron Obstruct Pulmon Dis, 2014, 9: 945-962.
50. Lee JH, Haselkorn T, Borish L, et al. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest, 2007, 132(6): 1882-1889.
51. 沈寧, 賀蓓. 應用噻托溴銨治療成人未控制哮喘. 中華醫學雜志, 2010, 90(42): 2955-2955.
52. 沈寧, 馬洪明, 陳秋冬, 等. 白三烯受體拮抗劑作為哮喘控制一線或附加治療藥物的評價. 中華醫學雜志, 2011, 91(28): 1960-1960.
53. Korn D, Van den Brande P, Potvin E, et al. Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study. Curr Med Res Opin, 2009, 25(2): 489-497.
54. Mirabelli MC, Beavers SF, Chatterjee AB. Active asthma and the prevalence of physician-diagnosed COPD. Lung, 2014, 192(5): 693-700.
55. Tashkin DP. Is it asthma, COPD, or something in between, and does it matter? Respiratory Care, 2012, 57(8): 1354-1356.
56. Tinkelman DG, Price DB, Nordyke RJ, et al. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma, 2006, 43(1): 75-80.
57. Burgess JA, Walters EH, Byrnes GB, et al. Who remembers whether they had asthma as children? J Asthma, 2006, 43(10): 727-730.
58. Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008, 31(4): 742-750.
59. D’Silva L, Hassan N, Wang HY, et al. Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice. Can Respir J, 2011, 18(3): 144-148.
60. Hancox RJ, Cowan DC, Aldridge RE, et al. Asthma phenotypes: consistency of classification using induced sputum. Respirology, 2012, 17(3): 461-466.
61. Van fleteren LE, Kocks JW, Stone IS, et al. Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? Thorax, 2014, 69(1): 72-79.
62. Nakawah MO, Hawkins C, Barbandi F. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome. J. Am. Board Fam. Med, 2013, 26(4): 470-477.
63. Louie S, Zeki AA, Schivo M, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev, Clin. Pharmacol, 2013, 6(2): 197-219.
64. 鄧玎玎, 周愛媛, 雙慶翠, 等. 支氣管哮喘-慢性阻塞性肺疾病重疊綜合征的診斷及治療現狀. 國際呼吸雜志. 2016, 13: 1023-1027.
65. Diaz-Guzman E, Mannino DM. Airway obstructive diseases in older adults: from detection to treatment. J Allergy Clin Immunol, 2010, 126(4): 702-709.
66. 孟珊珊, 閆冰迪, 王艷軍, 等. 支氣管哮喘-慢性阻塞性肺疾病重疊綜合征265例. 實用醫學雜志, 2015, 31(3): 437-438.
67. Montuschi P, Malerba M, Santini G, et al. Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping. Drug Discov Today, 2014, 19(12): 1928-1935.
68. Welte T, Miravitlles M, Hernandez P, et al. Efficacy and tolerability of budesonide/ formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2009, 180(8): 741-750.
69. Gershon AS, Campitelli MA, Croxford R, et al. Combination long-acting beta-agonists and inhaled corticosteroids compared with long acting beta-agonists alone in older adults with chronic obstructive pulmonary disease. JAMA, 2014, 312(11): 1114-1121.
70. Magnussen H, Bugnas B, van Noord J, et al. Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med, 2008, 102(1): 50-56.
71. Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N. Engl. J. Med, 2010, 363(18): 1715-1726.
72. Miravitlles M, Soler-Cataluna JJ, Calle M, et al. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J, 2013, 41(6): 1252-1256.
73. Leigh R, Pizzichini MM, Morris MM, et al. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J, 2006, 27(5): 964-971.
74. Chanez P, Vignola AM, O’Shaugnessy T, et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit CareMed, 1997, 155(5): 1529-1534.
75. Tomlinson JE, McMahon AD, Chaudhuri R, et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax, 2005, 60(4): 282-287.
76. Bellia V, Pistelli R, Catalano F, et al. Quality control of spirometry in the elderly. The SA. R. A. study. SAlute Respiration nell’Anziano=Respiratory Health in the Elderly. Am J Respir Crit Care Med, 2000, 161(4): 1094-1100.
77. McDonald VM, Higgins I, Gibson PG. Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges. Drugs Aging, 2013, 30(1): 1-17.
78. Contoli M, Baraldo S, Marku B, et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. J Allergy Clin Immunol, 2010, 125(4): 830-837.
79. Lange P, Celli B, Agusti A, et al. Lungfunction trajectories leading to chronic obstructive pulmonary disease. N Engl J Med, 2015, 373(2): 111-122.
80. Pavord ID. Complex airway disease: an approach to assessment and management. Lancet Respir Med. 2013, 1(1): 84-90.

Previous Article
伴多種胸部 CT 征象的韋格納肉芽腫病一例
Next Article
轉化生長因子-β₁、調節性 T 細胞與支氣管哮喘

Chinese Journal of Respiratory and Critical Care Medicine

哮喘-慢性阻塞性肺疾病重疊的臨床研究和診斷標準進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content